Stock Evaluator: Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care, Inc. TNDM

$19.43 0.42 2.21%
July 31, 2026 2:15:57 PM EST November 10, 2021 Volume: 985,715
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It’s flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Commentary & Analysis


Financial Summary

Share Statistics TNDM Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,303.1 $334.8 49%
Shares Out (Mil) 68.4 41.7 55%
Institutional Ownership 98.9% 77.3% 83%
Float (Mil) 62.9 34.7 53%
Beta 1.64 0.86 86%
Avg Daily Volume (000s) 1,697 266 79%
Price Change
(52-week)
13.9% 60.7% 57%
Growth TNDM Industry
Median
Percentile
(All Stocks)
Sales (5yr) 15.3% 11.8% 74%
Net Income (5yr) (42.9%) (5.8%) 8%
EPS (5yr) (40.1%) 10.7% 5
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (14.7%) (16.1%) 55%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 18 19 19
Current EPS ($0.319) ($0.685) $0.107
Month Ago EPS ($0.326) ($0.707) $0.078
# Rev Up 0 1 0
# Rev Down 1 0 1
Three Months Ago EPS ($0.294) ($0.801) ($0.027)
Year/Year Chg 7.0% (77.5%) (125.0%)
Financials TNDM Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1,028 $152 51%
Net Income (TTM) (Mil) ($95) ($11) 11%
EPS (TTM) ($1.395) ($0.500) 18%
Operating Cash Flow (TTM) (Mil) $20 ($2) 41%
Net Cash Flow (TTM) (Mil) $126 $1 80%
Long-Term Debt (Q1) (Mil) $715 $22 63%
Enterprise Value (Q1) (Mil) $1,225 $304 43%
Valuation TNDM Industry
Median
Percentile
(All Stocks)
P/B 9.85 2.88 90%
P/E na 30.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.9 na
Ratios TNDM Industry
Median
Percentile
(All Stocks)
Gross Margin 54.9% 59.1% 67%
Net Margin (9.2%) (7.7%) 21%
ROA (9.1%) (13.7%) 26%
ROE (65.7%) (15.9%) 13%
Liabilities to Assets 88.5% 44.9% 83%
F-Score 5 4 51%

Tandem Diabetes Care, Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors